{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihc2updv5nxmplpomqvhyjacviqc3zo3qyuxzyfwtaimfnwxnk5le",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mkzlro4a3jl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif6ivrqni7cpx2xwe4nuvvganjxzw6bxahkhbrlj6riikgftyc42q"
    },
    "mimeType": "image/webp",
    "size": 120868
  },
  "path": "/releases/2026/05/260502233915.htm",
  "publishedAt": "2026-05-04T01:42:05.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review of over 20,000 participants. Even more concerning, they may increase the risk of brain swelling and bleeding, sometimes without obvious symptoms.",
  "title": "Alzheimer’s drugs may not work and could raise brain risks"
}